Ten-year survival after indirect mitral annuloplasty with the Carillon Mitral Contour System in functional mitral regurgitation. A single-center followup from the REDUCE-FMR trial
Global Cardiology · 26.06.2026 · 4 (2)
DOI: 10.4081/cardio.2026.106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Cardiology, online erschienen am 26.06.2026. Verfasst von Janusz Lipiecki und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Indirect mitral annuloplasty with the Carillon Mitral Contour System reduces regurgitant volume, induces favorable left ventricular remodeling, and is associated with favorable survival rates through 6 years; however, longer term data are limited. This observational study included all 17 patients from a single center implanted with the Carillon device in the REDUCEF-MR trial. Patients had New York Heart Association class IIIV symptoms, left ventricular ejection fraction
Zitieren
APA
Lipiecki, J., Kalmucki, P., Miller, L. E., & Durel, N. (2026). Ten-year survival after indirect mitral annuloplasty with the Carillon Mitral Contour System in functional mitral regurgitation. A single-center followup from the REDUCE-FMR trial. Global Cardiology, 4(2). https://doi.org/10.4081/cardio.2026.106
Vancouver
Lipiecki J, Kalmucki P, Miller LE, Durel N. Ten-year survival after indirect mitral annuloplasty with the Carillon Mitral Contour System in functional mitral regurgitation. A single-center followup from the REDUCE-FMR trial. Global Cardiology. 2026;4(2). doi:10.4081/cardio.2026.106
BibTeX
@article{Lipiecki2026,
author = {Lipiecki, Janusz and Kalmucki, Piotr and Miller, Larry E. and Durel, Nicolas},
title = {Ten-year survival after indirect mitral annuloplasty with the Carillon Mitral Contour System in functional mitral regurgitation. A single-center followup from the REDUCE-FMR trial},
journal = {Global Cardiology},
year = {2026},
volume = {4},
number = {2},
doi = {10.4081/cardio.2026.106}
}
EUVIMED